We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Crucial Mitophagy Protein Identified

By LabMedica International staff writers
Posted on 05 Jan 2017
A receptor protein located on the inner mitochondrial membrane has been identified as a critical initiator of the process of mitochondrial destruction known as mitophagy.

The removal of unwanted or damaged mitochondria by the autophagic process known as mitophagy is essential for key events in development, cellular homeostasis, tumor suppression, and prevention of neurodegeneration and aging. More...
However, the precise mechanisms of mitophagy have not been elucidated.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) unraveled some of the secrets of mitophagy and described their findings in the December 22, 2016, online edition of the journal Cell.

They reported that they had identified the inner mitochondrial membrane protein, prohibitin 2 (PHB2), as a crucial mitophagy receptor involved in targeting mitochondria for autophagic degradation. PHB2 is located on the inner membrane of mitochondria, but is exposed when a mitochondrion's outer membrane ruptures. Should this occur, the LC3 (Microtubule-associated proteins 1A/1B light chain 3A) protein, which is present on the exterior of autophagosomes binds to PHB2. The autophagosome then transports the damaged mitochondrion to be destroyed by a lysosome.

The investigators also found that PHB2 was required for mitophagy induced by Parkin protein in mammalian cells and for the clearance of paternal mitochondria after embryonic fertilization in the flatworm C. elegans.

"The removal of damaged mitochondria by autophagy (a process called mitophagy) is important for cellular health," said senior author Dr. Beth Levine, professor of internal medicine and microbiology at the University of Texas Southwestern Medical Center. "By understanding how cells get rid of damaged mitochondria that contribute to cancer, neurodegenerative diseases, and aging, we may be able to develop treatments to prevent those processes."

Related Links:
University of Texas Southwestern Medical Center


New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Thyroid Test
Anti-Thyroid EIA Test
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.